| Literature DB >> 31797481 |
In Soo Ryu1, Seong Shoon Yoon1, Mee Jung Choi1, Young Eun Lee1, Ji Sun Kim1, Woo Hyun Kim1, Jae Hoon Cheong2, Hee Jin Kim2, Choon-Gon Jang3, Yong Sup Lee4, Scott C Steffensen5, Minhan Ka1, Dong Ho Woo1, Eun Young Jang1, Joung-Wook Seo1.
Abstract
3-fluoromethamphetamine (3-FMA), a derivative of methamphetamine (METH), produces behavioral impairment and deficits in dopaminergic transmission in the striatum of mice. The abuse potential of 3-FMA has not been fully characterized. The aim of this study was to evaluate the effects of 3-FMA on locomotor activity as well as its rewarding and reinforcing properties in the conditioned place preference (CPP) and self-administration procedures. Intravenous (i.v.) administration of 3-FMA (0.5 and 1.0 mg/kg) significantly increased locomotor activity in a dose-dependent manner in rats. In the CPP procedure, intraperitoneal administration of 3-FMA (10 and 30 mg/kg) produced a significant alteration in place preference in mice. In the self-administration paradigms, 3-FMA showed drug-taking behavior at the dose of 0.1 mg/kg/infusion (i.v.) during 2 hr sessions under fixed ratio schedules and high breakpoints at the dose of 0.3 and 1.0 mg/kg/infusion (i.v.) during 6 hr sessions under progressive ratio schedule of reinforcement in rats. A priming injection of 3-FMA (0.4 mg/kg, i.v.), METH (0.2 mg/kg, i.v.), or cocaine (2.0 mg/kg, i.v.) reinstated 3-FMA-seeking behavior after an extinction period in 3-FMA-trained rats during 2 hr session. Taken together, these findings demonstrate robust psychomotor, rewarding and reinforcing properties of 3-FMA, which may underlie its potential for compulsive use in humans.Entities:
Keywords: 3-fluoromethamphetamine; abuse potential; conditioned place preference; locomotor activity; reinstatement; self-administration
Mesh:
Substances:
Year: 2019 PMID: 31797481 DOI: 10.1111/adb.12846
Source DB: PubMed Journal: Addict Biol ISSN: 1355-6215 Impact factor: 4.280